# IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load

> **NCT00659386** · PHASE1 · UNKNOWN · sponsor: **Maastricht University Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Intravenous immunoglobulin therapy

## Key facts

- **NCT ID:** NCT00659386
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2009-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659386, "IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00659386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*